Paliperidone (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Paliperidone drug offered from Actavis Pharma, Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Paliperidone
SUBSTANCE NAME: PALIPERIDONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-09-24
END MARKETING DATE: 0000-00-00


Paliperidone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPaliperidone from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.5(mg/1)
START MARKETING DATE: 2015-09-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-3692_80dd24fd-b3da-4b5e-8519-61bf8b202d8d
PRODUCT NDC: 0591-3692
APPLICATION NUMBER: ANDA202645

Other PALIPERIDONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Paliperidone
Avera McKennan HospitalINVEGA
Carilion Materials ManagementPaliperidone
Janssen Pharmaceuticals, Inc.INVEGA
Mylan Institutional Inc.Paliperidone
Mylan Pharmaceuticals Inc.Paliperidone
Patriot Pharmaceuticals, LLCPaliperidone
Rebel Distributors CorpINVEGA
TYA PharmaceuticalsINVEGA